Abstract
Introduction: Extraskeletal Ewing sarcoma (EEwS) is a rare malignant tumor, and current international recommendations indicate systemic and local treatment like bone Ewing sarcoma (BEwS); to the best of our knowledge, very few studies tried to explore the clinical and genetic characteristics of this tumor, and the most appropriate treatment strategy remains uncertain. Methods: We reviewed 35 EEwS cases enrolled at Rizzoli Orthopedic Institute in Bologna, Italy, between 1988–2022. We performed RNA sequencing in 18 Ewing sarcoma cases, including 12 BEwSs and 6 EEwSs. We analyzed overall survival (OS), local relapse-free survival (LRFS), and metastasis-free survival (MFS) and the risk factors associated to survival. Results: Unsupervised hierarchical clustering showed no differences in the transcriptional profile between EEwS and BEwS. Five-year OS was 67% (95% confidence interval [CI]: 47–80), 5-year LRFS was 61% (95% CI: 43–75), and 5-year MFS was 55% (95% CI: 38–70). Recurrent tumors, larger than 8 cm, and elevated lactate dehydrogenase (LDH) serum value resulted to be negative prognostic factors. Conclusions: The finding/detection of a genetic profile that is indistinguishable between EEwS and BEwS confirms the view that the two subgroups belong to the same tumor entity and supports the use of a single therapeutic approach for Ewing sarcoma, regardless of the site of origin. Statistical evaluation showed that size bigger than 8 cm, elevated LDH, and recurrent tumors had a worse prognosis, suggesting a risk-stratification method for identifying patients for specific therapy treatment. However, larger, multicenter, prospective trials are called for to validate our findings.
Journal Section:
Research Article
References
1.
Balamuth
NJ
, Womer
RB
. Ewing’ s sarcoma
. Lancet Oncol
. 2010
;11
(2
):184
–92
. 2.
Abboud
A
, Masrouha
K
, Saliba
M
, Haidar
R
, Saab
R
, Khoury
N
, et al. Extraskeletal Ewing sarcoma: diagnosis, management and prognosis
. Oncol Lett
. 2021
;21
(5
):354
. 3.
4.
Manara
MC
, Pasello
M
, Scotlandi
K
. CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
. Genes
. 2018
;9
(3
):159
. 5.
Schwab
M
. IARC publications website: pathology and genetics of tumours of soft tissue and bone [internet]
. [cited 2020 Dec 15]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Pathology-And-Genetics-Of-Tumours-Of-Soft-Tissue-And-Bone-20026.
Elzi
DJ
, Song
M
, Houghton
PJ
, Chen
Y
, Shiio
Y
. The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma
. Genes Cancer
. 2015
;6
(11–12
):452
–61
. 7.
Applebaum
MA
, Worch
J
, Matthay
KK
, Goldsby
R
. Clinical features and outcomes in patients with extraskeletal ewing sarcoma
. 2011
. p. 3027
–32
.8.
Sbaraglia
M
, Bellan
E
, Dei Tos
AP
. The 2020 WHO classification of soft tissue tumours: news and perspectives
. Pathologica
. 2021
;113
(2
):70
–84
. 9.
Ahmad
R
, Mayol
BR
, Davis
M
, Rougraff
BT
. Extraskeletal Ewing’s sarcoma
. Cancer
. 1999
;85
(3
):725
–31
. 10.
Eaton
BR
, Claude
L
, Indelicato
DJ
, Vatner
R
, Yeh
B
, Schwarz
R
, et al. Ewing sarcoma
. Pediatr Blood Cancer
. 2021
;68
(Suppl 2
):e28355
. 11.
Boyce-Fappiano
D
, Guadagnolo
BA
, Ratan
R
, Wang
W-L
, Wagner
MJ
, Patel
S
, et al. Evaluating the soft tissue sarcoma paradigm for the local management of extraskeletal ewing sarcoma
. Oncologist
. 2021
;26
(3
):250
–60
. 12.
Bacci
G
, Ferrari
S
, Longhi
A
, Rimondini
S
, Versari
M
, Zanone
A
, et al. Prognostic significance of serum LDH in Ewing’s sarcoma of bone
. Oncol Rep
. 1999
;6
(4
):807
–11
. 13.
Picci
P
, Rougraff
BT
, Bacci
G
, Neff
JR
, Sangiorgi
L
, Cazzola
A
, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing’s sarcoma of the extremities
. J Clin Oncol
. 1993
;11
(9
):1763
–9
. 14.
Enneking
WF
, Spanier
SS
, Goodman
MA
. The classic: a system for the surgical staging of musculoskeletal sarcoma
. Clin Orthop Relat Res
. 2003
;415
:4
–18
. 15.
Bacci
G
, Ferrari
S
, Bertoni
F
, Rimondini
S
, Longhi
A
, Bacchini
P
, et al. Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli
. J Clin Oncol
. 2000
;18
(1
):4
–11
. 16.
Gronchi
A
, Miah
AB
, Dei Tos
AP
, Abecassis
N
, Bajpai
J
, Bauer
S
, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
. Ann Oncol
. 2021
;32
(11
):1348
–65
. 17.
Asaftei
SD
, Puma
N
, Paioli
A
, Petraz
M
, Morosi
C
, Podda
M
, et al. Front-line window therapy with temozolomide and irinotecan in patients with primary disseminated multifocal ewing sarcoma: results of the ISG/AIEOP EW-2 study
. Cancers
. 2021
;13
(12
):3046
. 18.
Palmerini
E
, Jones
RL
, Setola
E
, Picci
P
, Marchesi
E
, Luksch
R
, et al. Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
. Acta Oncol
. 2018
;57
(7
):958
–64
. 19.
Luksch
R
, Tienghi
A
, Hall
KS
, Fagioli
F
, Picci
P
, Barbieri
E
, et al. Primary metastatic Ewing ’ s family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
. Ann Oncol
. 2012
;23
(11
):2970
–6
. 20.
Dobin
A
, Davis
CA
, Schlesinger
F
, Drenkow
J
, Zaleski
C
, Jha
S
, et al. STAR: ultrafast universal RNA-seq aligner
. Bioinformatics
. 2013
;29
(1
):15
–21
. 21.
Liao
Y
, Smyth
GK
, Shi
W
. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
. Bioinformatics
. 2014
;30
(7
):923
–30
. 22.
Love
MI
, Huber
W
, Anders
S
. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
. Genome Biol
. 2014
;15
(12
):550
. 23.
Gu
Z
, Eils
R
, Schlesner
M
. Complex heatmaps reveal patterns and correlations in multidimensional genomic data
. Bioinformatics
. 2016
;32
(18
):2847
–9
. 24.
25.
BiocSingular
AL
. Singular value decomposition for bioconductor packages
. 2023
. Available from: https://github.com/LTLA/BiocSingular26.
Gröbner
SN
, Worst
BC
, Weischenfeldt
J
, Buchhalter
I
, Kleinheinz
K
, Rudneva
VA
, et al. The landscape of genomic alterations across childhood cancers
. Nature
. 2018
;555
(7696
):321
–7
. 27.
Franzetti
GA
, Laud-Duval
K
, Van Der Ent
W
, Brisac
A
, Irondelle
M
, Aubert
S
, et al. Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
. Oncogene
. 2017
;36
(25
):3505
–14
. 28.
Aynaud
MM
, Mirabeau
O
, Gruel
N
, Grossetête
S
, Boeva
V
, Durand
S
, et al. Transcriptional programs define intratumoral heterogeneity of ewing sarcoma at single-cell resolution
. Cell Rep
. 2020
;30
(6
):1767
–79.e6
. 29.
Visser
LL
, Bleijs
M
, Margaritis
T
, van de Wetering
M
, Holstege
FCP
, Clevers
H
. Ewing sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells
. Cancer Res Commun
. 2023
;3
(10
):2158
–69
. 30.
Cillo
AR
, Mukherjee
E
, Bailey
NG
, Onkar
S
, Daley
J
, Salgado
C
, et al. Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks
. Clin Cancer Res
. 2022
;28
(22
):4968
–82
. 31.
Cash
T
, McIlvaine
E
, Krailo
MD
, Lessnick
SL
, Lawlor
ER
, Laack
N
, et al. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: a report from the Children’s Oncology Group
. Pediatr Blood Cancer
. 2016
;63
(10
):1771
–9
. 32.
Murthy
SS
, Challa
S
, Raju
KVVN
, Rajappa
SJ
, Fonseca
D
, Gundimeda
SD
, et al. Ewing sarcoma with emphasis on extra-skeletal ewing sarcoma: a decade’s experience from a single centre in India
. Clin Pathol
. 2020
;13
:2632010X20970210
. 33.
Tural
D
, Molinas Mandel
N
, Dervisoglu
S
, Oner Dincbas
F
, Koca
S
, Colpan Oksuz
D
, et al. Extraskeletal Ewing’s sarcoma family of tumors in adults: prognostic factors and clinical outcome
. Jpn J Clin Oncol
. 2012
;42
(5
):420
–6
. 34.
Li
S
, Yang
Q
, Wang
H
, Wang
Z
, Zuo
D
, Cai
Z
, et al. Prognostic significance of serum lactate dehydrogenase levels in Ewing’s sarcoma: a meta-analysis
. Mol Clin Oncol
. 2016
;5
(6
):832
–8
. 35.
El WeshiAllam
AA
, Ajarim
D
, Al Dayel
F
, PantBazarbashiMemon
RSM
, Pant
R
, Bazarbashi
S
. Extraskeletal ewing ’ s sarcoma family of tumours in adults: analysis of 57 patients from a single institution
. Clin Oncol
. 2010
;22
(5
):374
–81
. 36.
Sinkovics
JG
, Plager
C
, Ayala
AG
, Lindberg
RD
, Samuels
ML
. Ewing sarcoma: its course and treatment in 50 adult patients
. Oncology
. 1980
;37
(2
):114
–9
. 37.
Lee
JA
, Kim
DH
, Lim
JS
, Koh
JS
, Kim
MS
, Kong
CB
, et al. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome
. Jpn J Clin Oncol
. 2010
;40
(11
):1060
–7
. 38.
Van Den Berg
H
, Heinen
RC
, Van Der Pal
HJ
, Merks
JHM
. Extra-osseous ewing sarcoma
. Pediatr Hematol Oncol
. 2009
;26
(4
):175
–85
. 39.
Gururangan
S
, Marina
NM
, Luo
X
, Parham
DM
, Tzen
CY
, Greenwald
CA
, et al. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing’s tumor with Ewing’s-directed therapy
. J Pediatr Hematol Oncol
. 1998
;20
(1
):55
–61
. 40.
Esen
SA
, Acikgoz
Y
, Bal
O
, Yildiz
B
, Ucar
G
, Dirikoc
M
, et al. A comparison of osseous and extraosseous ewing sarcoma
. J Coll Physicians Surg Pak
. 2021
;31
(1
):27
–33
. 41.
Lynch
AD
, Gani
F
, Meyer
CF
, Morris
CD
, Ahuja
N
, Johnston
FM
. Extraskeletal versus skeletal ewing sarcoma in the adult population: controversies in care
. Surg Oncol
. 2018
;27
(3
):373
–9
. 42.
Raney
RB
, Asmar
L
, Newton
WAJ
, Bagwell
C
, Breneman
JC
, Crist
W
, et al. Ewing’s sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991
. J Clin Oncol
. 1997
;15
(2
):574
–82
. 43.
Castex
MP
, Rubie
H
, Stevens
MCG
, Escribano
CC
, De Gauzy
JS
, Gomez-Brouchet
A
, et al. Extraosseous localized ewing tumors: improved outcome with anthracyclines - the French society of pediatric oncology and international society of pediatric oncology
. J Clin Oncol
. 2007
;25
(10
):1176
–82
. 44.
Qureshi
SS
, Laskar
S
, Kembhavi
S
, Talole
S
, Chinnaswamy
G
, Vora
T
, et al. Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin
. Pediatr Surg Int
. 2013
;29
(12
):1303
–9
. 45.
Livellara
V
, Bergamaschi
L
, Puma
N
, Chiaravalli
S
, Podda
M
, Casanova
M
, et al. Extraosseous Ewing sarcoma in children and adolescents: a retrospective series from a referral pediatric oncology center
. Pediatr Blood Cancer
. 2022
;69
(5
):e29512
–8
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
